Assessing Population-based Radiological brain health in Stroke Epidemiology (APRISE) Study
评估中风流行病学中基于人群的放射学脑健康 (APRISE) 研究
基本信息
- 批准号:10456166
- 负责人:
- 金额:$ 57.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAncillary StudyAreaAutomobile DrivingBiometryBlack PopulationsBlood VesselsBrain hemorrhageCarotid StenosisCause of DeathCerebrovascular DisordersCerebrumClinicalCollectionDataDiseaseEducational InterventionEpidemiologyEventFamilyFibrinolytic AgentsFundingFutureGeneticGoalsGuidelinesImageIncidenceIndividualInfrastructureInvestigationIschemiaIschemic StrokeKentuckyLacunar InfarctionsMagnetic Resonance ImagingMeasuresMicrovascular DysfunctionMinorModelingModernizationMorbidity - disease rateNational Institute of Neurological Disorders and StrokeOutcomePathway interactionsPatientsPopulationPopulation HeterogeneityPositioning AttributePredispositionPrevalencePublic HealthRadiologic FindingRadiology SpecialtyRecording of previous eventsRecurrenceResearch PriorityRiskRisk FactorsRoleSeveritiesSourceStrokeSurveysTimeTissuesUnited States National Institutes of HealthVascular DementiaWhite Matter HyperintensityWorkbasebiracialbrain healthcareercerebral atrophycerebrovascularclinical careclinical decision-makingclinical investigationcohortdisabilityepidemiology studyhigh riskimaging biomarkerimprovedinnovationmortalitymultidisciplinarynovelparent grantpopulation basedpredictive modelingracial disparityracial diversityspectrographstroke eventstroke patientstroke risktool
项目摘要
DESCRIPTION/ABSTRACT:
Stroke recurrence is a major public health problem. It has been understudied epidemiologically despite
comprising ~25% of all stroke in the US, and leading to higher morbidity and mortality compared to initial
events. Furthermore, compared to our understanding of the role of traditional risk factors for first stroke, we
have limited understanding of the risk factors for recurrent stroke. Radiological measures of small vessel and
large-vessel disease may provide a measure of a subject’s current “Brain Health” to predict future
cerebrovascular events and vascular dementia. Understanding small vessel disease in particular—manifesting
as white matter hyperintensity, microbleeds, lacunar infarcts, dilated perivascular spaces, and brain atrophy–is
a top NINDS priority. Although the Framingham risk score is widely used for clinical decision-making, and the
ABCD scores predict 90-day stroke risk among minor stroke/TIA patients, no clinical prediction tool in a
broader ischemic or a hemorrhagic stroke population-based cohort has been established. A Framingham-like
“Risk Function Tool for Secondary Stroke,” especially one incorporating the full gamut of modern imaging
parameters developed in a racially diverse population, would likely identify high-risk patients for targeted
education interventions, novel antithrombotics, and aggressive clinical care. Moreover, it may reveal novel
causal pathways and risk factors for future investigation. We propose an ancillary study to the ongoing Greater
Cincinnati/Northern Kentucky Stroke Study (GCKNSS) entitled APRISE (Assessing Population-based
Radiological brain health in Stroke Epidemiology). Our objective is to build on the GCNKSS infrastructure
to radiologically characterize the full stroke/TIA population of Greater Cincinnati/Northern Kentucky from 2015
and create the first modern, largely MRI-based characterization of brain health in a contemporary stroke/TIA
population. Our specific aim is to create a prediction model of cerebrovascular disease recurrence
(ischemic or hemorrhagic stroke) incorporating imaging parameters in a biracial, large-scale ischemic
stroke/TIA population using state-of-the-art modeling approaches. We will achieve these goals by
radiologically characterizing the stroke/TIA population (~2700 ischemic and ~525 hemorrhagic stroke, and
~1025 TIA patients) in the NIH-funded GCNKSS of a 1.4 million, biracial population. We will leverage the
extensive GCNKSS infrastructure, which is already in place to detect recurrent stroke, placing us in a unique
position to develop a recurrent stroke risk model using newly acquired radiologic data with remarkable
efficiency. The proposed study will allow the first and only population-based characterization of the entire
imaging spectrum of brain health in stroke/TIA patients. Our multi-disciplinary team with imaging,
epidemiology, outcomes, and biostatistics expertise will address NINDS priority research areas with precision
and innovation currently unavailable.
描述/摘要:
中风复发是一个重大的公共卫生问题。尽管它在流行病学方面尚未得到充分研究
约占美国所有中风的 25%,与最初相比,导致发病率和死亡率更高
事件。此外,与我们对首次中风的传统危险因素的作用的理解相比,我们
对复发性中风的危险因素了解有限。小型血管和血管的放射测量
大血管疾病可以提供受试者当前“大脑健康”的衡量标准以预测未来
脑血管事件和血管性痴呆。特别了解小血管疾病——表现
如白质高信号、微出血、腔隙性梗塞、血管周围空间扩张和脑萎缩
NINDS 的首要优先事项。尽管弗雷明汉风险评分广泛用于临床决策,并且
ABCD 评分可以预测轻微中风/TIA 患者 90 天的中风风险,目前尚无临床预测工具
更广泛的缺血性或出血性中风人群队列已经建立。类似弗雷明汉的
“继发性中风的风险函数工具”,尤其是一种融合了现代影像学全部功能的工具
在种族多样化人群中开发的参数可能会识别高风险患者以进行有针对性的治疗
教育干预、新型抗血栓药物和积极的临床护理。此外,它还可能揭示新颖的
未来调查的因果路径和风险因素。我们建议对正在进行的更大的研究进行一项辅助研究
辛辛那提/北肯塔基州中风研究 (GCKNSS),题为 APRISE(基于人口的评估)
中风流行病学中的放射学脑健康)。我们的目标是建立在 GCNKSS 基础设施之上
从 2015 年起对大辛辛那提/北肯塔基州的全中风/TIA 人群进行放射学表征
并创建了第一个现代的、主要基于 MRI 的当代中风/TIA 大脑健康特征
人口。我们的具体目标是创建脑血管疾病复发的预测模型
(缺血性或出血性中风)将成像参数纳入双种族、大规模缺血性中风
使用最先进的建模方法对中风/TIA 人群进行研究。我们将通过以下方式实现这些目标
中风/TIA 人群的放射学特征(约 2700 名缺血性中风和约 525 名出血性中风,以及
约 1025 名 TIA 患者)在 NIH 资助的 GCNKSS 中对 140 万混血人口进行了研究。我们将利用
广泛的 GCNKSS 基础设施已经到位,可以检测复发性中风,使我们处于独特的地位
使用新获得的放射学数据开发复发性中风风险模型的立场
效率。拟议的研究将允许第一个也是唯一一个基于人群的整个特征
中风/TIA 患者大脑健康的成像光谱。我们的多学科团队拥有影像学、
流行病学、结果和生物统计学专业知识将精确解决 NINDS 的优先研究领域
目前还无法实现创新。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Automated grading of enlarged perivascular spaces in clinical imaging data of an acute stroke cohort using an interpretable, 3D deep learning framework.
- DOI:10.1038/s41598-021-04287-4
- 发表时间:2022-01-17
- 期刊:
- 影响因子:4.6
- 作者:Williamson BJ;Khandwala V;Wang D;Maloney T;Sucharew H;Horn P;Haverbusch M;Alwell K;Gangatirkar S;Mahammedi A;Wang LL;Tomsick T;Gaskill-Shipley M;Cornelius R;Khatri P;Kissela B;Vagal A
- 通讯作者:Vagal A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRETT M KISSELA其他文献
BRETT M KISSELA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRETT M KISSELA', 18)}}的其他基金
APRISE Dementia (Assessing Population-based Radiological brain health in Stroke Epidemiology-Dementia)
APRISE 痴呆(中风流行病学-痴呆中基于人群的放射学脑健康评估)
- 批准号:
10029149 - 财政年份:2020
- 资助金额:
$ 57.44万 - 项目类别:
Assessing Population-based Radiological brain health in Stroke Epidemiology (APRISE) Study
评估中风流行病学中基于人群的放射学脑健康 (APRISE) 研究
- 批准号:
10220148 - 财政年份:2018
- 资助金额:
$ 57.44万 - 项目类别:
Assessing Population-based Radiological brain health in Stroke Epidemiology (APRISE) Study
评估中风流行病学中基于人群的放射学脑健康 (APRISE) 研究
- 批准号:
9975234 - 财政年份:2018
- 资助金额:
$ 57.44万 - 项目类别:
Outcome and Quality of Life after Diabetic Stroke
糖尿病中风后的结果和生活质量
- 批准号:
6696309 - 财政年份:2003
- 资助金额:
$ 57.44万 - 项目类别:
Outcome and Quality of Life after Diabetic Stroke
糖尿病中风后的结果和生活质量
- 批准号:
7004481 - 财政年份:2003
- 资助金额:
$ 57.44万 - 项目类别:
Outcome and Quality of Life after Diabetic Stroke
糖尿病中风后的结果和生活质量
- 批准号:
6560309 - 财政年份:2003
- 资助金额:
$ 57.44万 - 项目类别:
Outcome and Quality of Life after Diabetic Stroke
糖尿病中风后的结果和生活质量
- 批准号:
6826225 - 财政年份:2003
- 资助金额:
$ 57.44万 - 项目类别:
Outcome and Quality of Life after Diabetic Stroke
糖尿病中风后的结果和生活质量
- 批准号:
7162975 - 财政年份:2003
- 资助金额:
$ 57.44万 - 项目类别:
Comparison of Hemorrhagic & Ischemic Stroke Among Blacks and Whites
出血性比较
- 批准号:
8520995 - 财政年份:1992
- 资助金额:
$ 57.44万 - 项目类别:
Comparison of Hemorrhagic & Ischemic Stroke Among Blacks and Whites
出血性比较
- 批准号:
7654859 - 财政年份:1992
- 资助金额:
$ 57.44万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 57.44万 - 项目类别:
Research Grant














{{item.name}}会员




